A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Hoffmann-La Roche
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ningbo Medical Center Lihuili Hospital
AstraZeneca
Institut Cancerologie de l'Ouest
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AbbVie
Providence Health & Services
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
National Cancer Center Hospital East
Baylor College of Medicine
Taiho Oncology, Inc.
Washington University School of Medicine
Mirati Therapeutics Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Astellas Pharma Inc
Vejle Hospital
Bristol-Myers Squibb
Arcus Biosciences, Inc.
Ono Pharmaceutical Co., Ltd.
AstraZeneca
Ruijin Hospital
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
AstraZeneca
Centre Oscar Lambret
AstraZeneca
SCRI Development Innovations, LLC
Multitude Therapeutics Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Nanjing Leads Biolabs Co.,Ltd
Yale University
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Medical College of Wisconsin
Fudan University
Sixth Affiliated Hospital, Sun Yat-sen University
I-Mab Biopharma US Limited
Tianjin Medical University Cancer Institute and Hospital
Seagen Inc.
AstraZeneca